Octagon Capital Advisors LP Alpine Immune Sciences, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$8.54 - $20.22 $4.2 Million - $9.93 Million
491,300 Added 65.51%
1,241,300 $23.7 Million
Q2 2023

Aug 14, 2023
SELL
$6.84 - $11.91 $3.09 Million - $5.38 Million
-452,000 Reduced 37.6%
750,000 $7.71 Million
Q1 2023

May 15, 2023
SELL
$7.0 - $8.75 $161,000 - $201,250
-23,000 Reduced 1.88%
1,202,000 $9.28 Million
Q4 2022

Feb 14, 2023
BUY
$5.45 - $7.35 $6.68 Million - $9 Million
1,225,000 New
1,225,000 $9 Million

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email